Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study.

Bogani, Giorgio; Papadia, Andrea; Buda, Alessandro; Casarin, Jvan; Di Donato, Violante; Gasparri, Maria Luisa; Plotti, Francesco; Pinelli, Ciro; Paderno, Maria Chiara; Lopez, Salvatore; Perrone, Anna Myriam; Barra, Fabio; Guerrisi, Rocco; Brusadelli, Claudia; Cromi, Antonella; Ferrari, Debora; Chiapp, Valentina; Signorelli, Mauro; Leone Roberti Maggiore, Umberto; Ditto, Antonino; ... (2021). Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study. Gynecologic oncology, 161(1), pp. 122-129. Elsevier 10.1016/j.ygyno.2021.01.008

[img] Text
33485641_1-s2.0-S009082582100055X-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (382kB)

OBJECTIVE

Sentinel node mapping (SLN) has replaced lymphadenectomy for staging surgery in apparent early-stage low and intermediate risk endometrial cancer (EC). Only limited data about the adoption of SNM in high risk EC is still available. Here, we evaluate the outcomes of high-risk EC undergoing SNM (with or without back-up lymphadenectomy).

METHODS

This is a multi-institutional international retrospective study, evaluating data of high-risk (FIGO grade 3 endometrioid EC with myometrial invasion >50% and non-endometrioid histology) EC patients undergoing SNM followed by back-up lymphadenectomy and SNM alone.

RESULTS

Chart of consecutive 196 patients were evaluated. The study population included 83 and 113 patients with endometrioid and non-endometrioid EC, respectively. SNM alone and SNM followed by back-up lymphadenectomy were performed in 50 and 146 patients, respectively. Among patients having SNM alone, 14 (28%) were diagnosed with nodal disease. In the group of patients undergoing SNM plus back-up lymphadenectomy 34 (23.2%) were diagnosed with nodal disease via SNM. Back-up lymphadenectomy identified 2 (1%) additional patients with nodal disease (in the para-aortic area). Back-up lymphadenectomy allowed to remove adjunctive positive nodes in 16 (11%) patients. After the adoption of propensity-matched algorithm, we observed that patients undergoing SNM plus back-up lymphadenectomy experienced similar disease-free survival (p = 0.416, log-rank test) and overall survival (p = 0.940, log-rank test) than patients undergoing SLN alone.

CONCLUSIONS

Although the small sample size, and the retrospective study design this study highlighted that type of nodal assessment did not impact survival outcomes in high-risk EC. Theoretically, back-up lymphadenectomy would be useful in improving the removal of positive nodes, but its therapeutic value remains controversial. Further prospective evidence is needed.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Gynaecology

UniBE Contributor:

Mueller, Michael

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0090-8258

Publisher:

Elsevier

Language:

English

Submitter:

Monika Zehr

Date Deposited:

25 Jan 2022 15:47

Last Modified:

05 Dec 2022 16:00

Publisher DOI:

10.1016/j.ygyno.2021.01.008

PubMed ID:

33485641

Uncontrolled Keywords:

Endometrial cancer Lymphadenectomy Sentinel node Staging Survival

BORIS DOI:

10.48350/163599

URI:

https://boris.unibe.ch/id/eprint/163599

Actions (login required)

Edit item Edit item
Provide Feedback